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Background: We have previously demonstrated that cigarette smoke is associated with a significant reduction of
retinoic acid in rat lungs and the formation of tracheal precancerous lesions. However, the underlying mechanism
of cancer risk induced by vitamin A deficiency is unclear. The purpose of this study was to determine whether the
cigarette smoke-induced depletion of vitamin A is related to changes in lung cancer risk-related molecular markers.
Results: We investigated the roles of the retinoic acid receptors (RARs) as well as other biomarkers for potential
cancer risk in the lungs of rats exposed to cigarette smoke. Twenty-four male weanling rats were fed a purified diet
and divided equally into four groups. Three experimental groups were exposed to increasing doses of cigarette
smoke from 20, 40 or 60 commercial cigarettes/day for 5 days/week. After 6 weeks, the retinoic acid concentrations
in the lung tissue as measured via high performance liquid chromatography (HPLC) significantly decreased (P < 0.01) in
cigarette smoke exposed groups. Western Blot analysis revealed that cigarette smoke exposure increased lung protein
expression of RAR α in a threshold manner and decreased RAR β and RAR γ expression in a dose-dependent
fashion. Protein expressions of cyclin E and proliferating cell nuclear antigen (PCNA) were increased significantly
in a dose-dependent manner in cigarette smoke exposed-groups. Additionally, there was a significant increase in
protein expression of cJun and cyclin D1 demonstrating a threshold effect similar to that exhibited by RARα,
suggesting a potential independent signaling pathway for RARα in lung carcinogenesis.
Conclusions: Findings from this study suggest that cigarette smoke-induced lung retinoic acid depletion may
involve two independent pathways, RARα- and RARβ-mediated, responsible for the increased cancer risk associated with
cigarette smoke-induced vitamin A deficiency.
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Lung cancer mainly caused by cigarette smoking re-
mains the leading cause of cancer death in both men
and women in the United States [1]. Understanding the
mechanisms of cigarette smoke-induced lung cancer is
an important area of research. Very little is known about
how micronutrients such as vitamin A play a role in pro-
tecting against lung cancer. Two large clinical trials, the
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carotene had an increased risk for developing cancer
when compared to smokers without β-carotene supple-
mentation [2]. A research group at Tufts University
found that when ferrets, having β-carotene metabolism
similar to humans, were supplemented with β-carotene
and exposed to cigarette smoke, lung concentration of
retinoic acid was reduced as was RAR-β expression, but
cell proliferation markers were elevated [2]. The investi-
gators suggested that the adverse effects upon vitamin A
status were largely attributed to the interaction of the
high dose of β-carotene and the cigarette smoke. To our
knowledge no one has determined the effect of increased
doses of cigarette smoke on lung retinoic acid and lung
cancer risk-related molecular markers using a rat model.distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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standing of the underlying mechanisms for cigarette
smoke-induced cancer and may lead to new strategies
for decreasing lung cancer risk.
Vitamin A deficiency has been reported to cause pre-
neoplastic changes in tracheal [3] and bronchial epithe-
lium and to be associated with an increased risk of lung
cancer [4, 5]. The loss of retinoic acid receptor beta
(RARβ), one of the vitamin A nuclear receptors, is
partly responsible for the lung carcinogenesis in vita-
min A deficient individuals [6]. Retinoic acid receptor β
is believed to promote transcription of tumor suppres-
sor genes and has been found to be decreased in many
preneoplastic lung cancers [7, 8]; therefore, decreased
expression of RARβ has been suggested as a biomarker
for lung cancer risk. How cigarette smoke-induced
depletion of lung retinoic acid alters RARβ in rats is
not known.
In contrast to the protective effects of RARβ, studies
have linked increased expression of RARα with formation
of tumors of the breast [9] and cervix [10], potentially by
way of an estrogen-mediated pathway [9]. Additionally,
vitamin A deficiency is linked with an increased expres-
sion of RARα, in contrast with the decreased expression
of RARβ [11]. The precise mechanism of how RARα over-
expression increases risk of lung cancer-related tumor
formation is presently unknown.
Our previous study found that exposure to cigarette
smoke decreased vitamin A level in lung tissue and was
associated with precancerous lesions in the trachea [3].
To further understand the underlying mechanisms by
which vitamin A deficiency might induce lung cancer,
eight proteins including retinoic acid receptors, cell
cyclins, proliferation markers, and nuclear transcription
factors were selected and their nuclear expression was
measured by Western blot.
Specifically, we investigated how the vitamin A deple-
tion induced by cigarette smoke is related to decreased
expression of RARβ, a potential cancer risk factor. Since
dysregulation of the cell cycle is a prerequisite for the
formation of most malignant tumors [12], we further in-
vestigated the impact of exposure to cigarette smoke on
cell cycle checkpoints. Cyclins are one of the check-
points in cell cycle, and their abundance is rate-limiting
for progression through the different stages of the cell
cycle. Another molecular marker for cell proliferation
and cancer is nuclear transcription factor activator
protein-1 (AP-1). AP-1 is a dimeric transcription factor
that consists of homodimers and heterodimers of Jun
(c-Jun, JunB, and JunD) and Fos (c-Fos, FosB, Fra1, and
Fra2) [13, 14] or other transcription factors and pro-
teins. The c-Jun has been found to play an integral role
in lung cancer formation [15], yet its precise role in the
signaling mechanism and its relation to the RARpathway(s) remains unclear. Thus, the objective of this
study was to determine how cigarette smoke-induced
lung retinoic acid depletion altered lung RARs and
their relationship to cancer-related cell proliferation
markers and cyclin expression. We exposed rats to
increasing doses of cigarette smoke for six weeks and
then quantified lung retinoic acid and the protein
expression of RARs, cell proliferation markers, and
cyclins.Methods
Animals and treatment
Male Sprague–Dawley weanling rats (range of weights:
50–75 g, Harlan Sprague Dawley, Indianapolis, IN)
were housed individually in stainless steel cages at
room temperature, 24 °C, under a 12-h light:dark cycle
(light 0600–1800 h) with a relative humidity of 50 %.
Male rats were chosen because they were previously
shown to develop precancerous lesions in response to
cigarette smoke-induced vitamin A deficiency. It will be
important to evaluate these effects in female rats in future
experiments. Animal care and use were approved by the
Institutional Animal Care and Use Committee of Kansas
State University. Rats were fed a standard AIN-93G diet
[16] and water. Food intake was recorded daily and body
weight was measured weekly. All groups were pair-fed
throughout the entirety of the experiment. The cigarette
smoke-treated rats were pair-fed to match the intake of
the control group, which was the group that was exposed
to air. This was to control for any potential reduced food
intake of the cigarette smoke-exposed rats.Cigarette smoke exposure
Approximately one month old rats were randomly di-
vided into four groups of six rats per group, and were
exposed to air (control), one-pack, two-packs, and three-
packs of cigarettes daily (nonfiltered commercial cigarette,
20 cigarettes/pack) for six weeks. The cigarette smoke
treatment was modeled after previously published studies
[3]. To model cigarette smoke exposure, rats were placed
in a plastic chamber that was 65 cm long, 50 cm wide,
and 45 cm high with three holes, two for holding two
cigarettes at one end of the chamber and another hole on
the opposite side of the chamber connected to a tube at-
tached to a Leeson vacuum pump (model # A6C17EB20.1;
Labconco, Kansas City, MO). The rats were exposed to
the cigarette smoke of four standard cigarettes for 5 min
followed by 5 min of air until all the cigarettes assigned to
the group were consumed. One pack of cigarettes was
considered one session and at least two hours of break
were given between sessions. The extent of cigarette smoke
exposure was ascertained by measuring total particulate
matter inhaled and is noted in our previous study [3].
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performance liquid chromatography (HPLC)
Lungs were collected under yellow lights following ter-
mination of the study and immediately frozen in liquid ni-
trogen and kept at −70 °C until analysis. The lipid
components were extracted from minced tissue, ~200 mg
by a standardized method developed by Barua and Olson
[17]. Tissue was ground in liquid nitrogen and then trans-
ferred to 10 mL of 2-propanol-dichloromethane (2:1, v/v)
plus 0.1 % butylated hydroxytoluene (1 mg/mL). Twenty
μL of retinyl acetate was added as the internal standard to
the solution. The mixture was vortexed for 1 min and
then stored under argon at −20 °C overnight. The follow-
ing day, the mixture was vortexed again and returned to
freezer. On the third day, the mixture was vortexed, and
then filtered through 0.45 um syringe filter. The filtrate
was evaporated to dryness under nitrogen. The residue
was dissolved in 200 μL 2-propanol-dichloromethane
(2:1, v/v). An aliquot of 50 μL was injected onto the
HPLC system for analysis according to the procedure
by Barua and Olson [17]. The concentration of retinoic
acid was determined using the Beckman System Gold
software (Beckman Instruments, Fullerton CA) and a
3-μm Microsorb-MV column (4.6 x 100 mm) (Rainin,
Woburn, MA), which was preceded by a guard column
of C18. The solvent system consisted of methanol–
water (3:1, v/v) containing 10 mM ammonium acetate
(solvent A) and methanol-dichloromethane (4:1, v/v)
(solvent B). The flow rate was 0.8 mL/min. A linear
gradient was formed from solvent A to solvent B over a
period of 15 min, followed by isocratic elution with
solvent B (100 %), for another 15 min. At the end of
the run, the gradient was reversed to initial conditions
by applying a linear gradient of 5 min. The column was
then allowed to equilibrate for 10 min with solvent A
before the next run. Detection was monitored at 340 nm
(Model 166, Beckman Instruments, San Ramon, CA).
Under these conditions, all-trans retinoic acid and, all-
trans retinyl acetate and all-trans retinyl palmitate was
eluted at ~10.5, 12.1 and 15.7 mins, respectively. The re-
covery rates were 91 % for all-trans retinoic acid, 94 % for
all-trans retinyl acetate and 92 % for all-trans retinyl
palmitate
Nuclear extraction procedure
The right lobe of the lung was immediately frozen at the
end of the study and the tissue stored at 70 °C until ana-
lysis. In previous studies we used the right lobe of the lung
for biochemical analysis and the left lobe for pathological
evaluations [3]. The lung tissue nuclei were extracted as
follows. Approximately, 0.15 g (1/3 of the right lobe) was
placed in ice cold buffer A (20 mM Tris/HCl pH 7.8,
1 mM EDTA, 0.1 M NaCl, 1 mM phenylmethylsufonyl
fluoride, and 1 μg/mL of each of the following: aprotinin,leupeptin and pepstain) and homogenized with a glass-
teflon homogenizer (Con-Torque Eberbach Company
Ann Arbor, MI). The homogenate was then centrifuged
at 2000 × g for 15 min (Allegra 25R, Beckman Coulter).
The supernatant was then removed, and the pellet was
re-extracted using buffer B (buffer A with NaCl in-
creased to 0.6 M) by tearing the pellet and vortexing in
order to maximize the nuclear amount in the sample.
The solution was then covered with mineral oil and
spun at 190,000 × g using an ultracentrifuge (Optima
L-90 K, Bechman Coulter). The supernatant was then
removed by syringe and stored at −70 °C until analysis.
Protein concentration was quantified using a spectro-
photometer (UV-1601PC, Shimadzu).
Western blot
Approximately 50 μg of nuclear extract in Tris lysis
buffer was separated on 1.5 mm 12 % formaldehyde
minigels. Protein concentration was measured by the
Bio-Rad protein assay (Bio-Rad, Hercules, CA). The sam-
ple volumes were calculated to produce equal protein
content. The protein was then transferred to a nitrocellu-
lose membrane (Bio Rad, Hercules, CA) using Tris-
Glysine Buffer pH 8.3 and blocked one hour at room
temperature in a 5 % dry milk PBS solution. Antibodies
against retinoic acid receptors α, β, γ, cyclin D1 and E,
proliferating cell nuclear antigen (PCNA), and c-Jun and
c-Fos were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). An antibody against β actin was used
for loading control (data are not provided in this paper).
Antibodies after dilution recommended by the manufac-
turer were incubated overnight at 4 °C. The blots were
washed and then incubated with secondary antibody
(1:1000, Santa Cruz, CA). The blots were visualized using
Chemi Glow West (Alpha Innotech Corporation) on a
Fluorochem 8800 (Alpha Innotech Corporation) imaging
system. The degree of expression of immunodetected
signaling molecules was measured by densitometry.
Statistical analysis
All data are presented as means ± SEM. Treatment effects
were analyzed using one-way ANOVA with the general
linear model procedure (SAS Institute, Cary, NC). In all
analyses, P < 0.05 was considered significant. The correl-
ation coefficients of each pair of groups are calculated in
SAS PROC CORR.
Results
Concentrations of retinoic acid were decreased in lungs
exposed to cigarette smoke
All animals completed the cigarette smoke exposure
treatment. The concentration of retinoic acid in lungs
was decreased when exposed to 2-pack and 3-pack of
cigarettes smoke (P < 0.021, Fig. 1), but not significantly
Fig. 1 Retinoic Acid Level in Lungs Exposed to Cigarette Smoke. The
all-trans retinoic acid level in lungs exposed to different doses of
cigarette smoke for 6 weeks. Values are mean ± SEM, n = 6. Groups
with different letters are significantly different, P < 0.05
Fig. 2 Western Blot Analysis for RAR Levels. Protein expressions
of retinoic acid receptors (RARs: RARα, β, γ) in lungs exposed to
different doses of cigarette smoke for 6 weeks. Representative
Western Blot analyses are shown that used anti-RARα, anti-RARβ
and anti-RARγ antibodies. The size of the detected RARα, RARβ
and RARγ were all 53 kilodaltons (kDa). The intensity of the
protein signal was determined by densitometry analysis (three
samples in each group). The relative protein values in the three
treatment groups were calculated as a mean value ± standard
deviation (SD) of the data relative (ratio) to control with the
control set at 1.0. Different letters represent significant difference
among groups (P < 0.05)
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of cigarettes when compared to the control group.
Expressions of RARβ and RAR γ were decreased in lungs
exposed to cigarette smoke
The expression of RARβ was significantly reduced by
more than 50 % in the group that was exposed to one
pack of cigarettes and undetectable in the other two
cigarette smoke-treated groups using Western blot ana-
lysis. A representative sample of RARβ protein expres-
sion is depicted in Fig. 2. High doses of cigarette
smoking exposure (2 and 3 packs) significantly (P < 0.05)
decreased RAR γ expression.
Expression of RARα was increased in lungs exposed to a
three pack dose of cigarette smoke
The expression of RARα was significantly increased in
the group that was exposed to three packs of cigarettes
using Western blot analysis (P < 0.038). A representa-
tive sample of RARα protein expression is depicted in
Fig. 2. There appears to be a dose threshold for the RARα
lung response when exposed to increasing amounts of
cigarette smoke.
Expressions of proliferation indicators: PCNA and cJun
were increased
A strong proliferative response in lungs either indicated
by PCNA or by cJun was observed in cigarette smoke-
treated groups. The expression of cJun significantly
increased only in the treatment group that was exposed
to 3-pack of cigarette smoke (Fig. 2, P < 0.001). There
was a dose-dependent response found between cigarette
smoke exposure and PNCA. The expression of PCNA
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ure was increased (P < 0.001).Cyclins E and D1 were increased in lungs exposed to
cigarette smoke
Two G1 phase cyclins were investigated in this study.
Cyclin E was found to be significantly increased in all
three treatment groups (Fig. 3, P < 0.05), exhibiting a
dose-dependent response. However, for cyclin D1, there
was no dose-dependent response, and only the group ex-
posed to the highest dose of cigarette smoke had signifi-
cantly increased expression compared to the control
group and other two groups.Fig. 3 Western Blot Analysis for cJun and PCNA. Protein expressions of cJu
6 weeks. Representative Western Blot analyses are shown that used anti-cJu
were 39 kDa and 36 kDa, respectively. The intensity of the protein signal w
The relative protein values in the three treatment groups were calculated a
control with the control set at 1.0. Different letters represent significant diffLinear correlation coefficients between levels of gene
expression among different groups
The protein level of RARβ in rat lung was significantly
decreased and directly correlated with the concentration
of retinoic acid (P < 0.001) in response to increasing ex-
posure to cigarette smoke. The responses of RARβ and
retinoic acid to the increased cigarette smoke exposure
were inversely related to the level of cyclin E (P < 0.001)
and PCNA (P < 0.05), but not significantly associated
with the expression of cyclin D1 or cJun (Table 1). Cyc-
lin D1 was significantly correlated with cJun (P < 0.001)
and with PCNA (P < 0.05). The cigarette smoke response
curve for RARα was similar to that of cyclin D1 and
cJun (Figs. 2, 3, and 4). There was no significant increasen and PCNA in lungs exposed to different doses of cigarette smoke for
n, and anti-PCNA antibodies. The size of the detected cJun and PCNA
as determined by densitometry analysis (three samples in each group).
s a mean value ± standard deviation (SD) of the data relative (ratio) to
erence among groups (P < 0.05)
Table 1 Correlation Coefficients
Correlation for Retinoic Acid and Lung Cancer-Related Markers
Measurements RARβ cJun PCNA cyclinD1 cyclinE RA
RARβ 1.00 - - - - -
cJun −0.53 1.00 - - - -
PCNA −0.89* 0.81* 1.00 - - -
cyclinD1 −0.50 0.98** 0.80* 1.00 - -
cyclinE −0.98** 0.56 0.90* 0.54 1.00 -
RA 0.96** −0.53 −0.84* −0.50 −0.95** 1.00
Linear correlation coefficients between levels of protein expression in the
different groups. This table shows the linear correlations between levels of
protein expressions and retinoic acid concentration among different groups.
Correlation coefficients are designated by a star * and two star ** to indicate
significance of P < 0.05 and P < 0.001, respectively. All other correlations were
not significant
RA retinoic acid, RAR retinoic acid receptor, PCNA proliferating cellular nuclear
antigen
Fig. 4 Western Blot Analysis for Cell Cyclins. Protein expressions of
cyclins E and D1 in lungs exposed to different doses of cigarette
smoke for 6 weeks. Representative Western Blot analyses are shown
that used anti-cyclin E, and anti-cyclin D1 antibodies. The size of the
detected cyclin E and D1 were 50 kDa and 36 kDa, respectively. The
intensity of the protein signal was determined by densitometry
analysis (three samples in each group). The relative protein values
in the three treatment groups were calculated as a mean value ±
standard deviation (SD) of the data relative (ratio) to control with
the control set at 1.0. Different letters represent significant difference
among groups (P < 0.05)
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cigarette smoke (one or two packs/d), but a significant
increase in all three at the highest dose of cigarette
smoke (three packs).
Discussion
In this study, we investigated how increasing exposure
to cigarette smoke depleted retinoic acid in rat lung
tissue and how this depletion was associated with
increased lung cancer risk via changes in protein levels
of specific biomarkers for cell proliferation and cell cycle
transition. It is well-known that cigarette smoke contains
numerous radicals that may deplete vitamin A, including
both carbon-centered and oxygen-centered products
from NO/NO2 reactions with reactive compounds such
as isoprene in smoke. In addition, benzopyrene, a car-
cinogen in cigarette smoke, has been found to deplete
lung and liver vitamin A levels when rats are fed benzo-
pyrene [18]. We found that cigarette smoke exposure
decreased both the lung retinoic acid concentration and
the protein levels of RARβ in a dose-dependent manner
while increasing expression of RARα in a threshold-
dependent response. Expression of two cell proliferation
markers, cJun and PCNA, increased. In addition, the
expression of two G1 phase cyclins, D1 and E, were
increased in response to cigarette smoke exposure.
This study presents the first evidence that six-week
exposure to one, two, and three packs of cigarettes per
day, five days per week, depletes lung retinoic acid in
rats and is associated with increasing molecular markers
for cancer while depleting the tumor suppressor RARβ.
In a previous study, we exposed rats to two packs of
cigarettes per day for four weeks and used microarray
analysis to discover that dietary retinoic acid down-
regulated genes that promoted cell divisions/prolifera-
tion in response to cigarette smoke [19]. Additionally,
we have shown that two-pack cigarette exposure per day
over six weeks depleted lung retinol and was associated
with precancerous tracheal lesions and emphysema [3].
Cigarette smoke-induced depletion of lung retinoic acid
has been reported in ferrets [8]. In addition, airborne
particulate matter which contains pentachlorophenol,
also in cigarette smoke, depleted lung vitamin A [20] as
did benzopyrene the cigarette smoke carcinogen [18].
Role of RARβ in lung cancer
RARβ expression was decreased in one-pack of cigarette
smoke exposure and undetectable in two-pack and three-
pack doses. Because many studies suggest a tumor sup-
pressor role for RARβ [21] and reduced RARβ expression
is found in about 45-50 % of lung cancers [22, 23], the
decreased expression of RARβ observed in this study
suggests a greater risk for development and/or promotion
of lung cancer. The reduction in RARβ expression may be
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genomic methylation or histone deacetylation [24–26].
Hypermethylation of the RARβ promoter region is an
early event in lung carcinogenesis and is one of the most
frequent methylation defects detected in the histopatho-
logically normal bronchial epithelium of heavy smokers
[27]. Thus, the loss of RARβ expression may be an early
event leading to lung carcinogenesis [22, 28].
The concentration of retinoic acid was decreased sig-
nificantly in the cigarette smoke-exposed groups which
strongly correlated with the decreased expression of
RARβ. The decreased retinoic acid likely preceded the
loss of RARβ expression since others have found that
all-trans-retinoic acid is a potent inducer for mRNA for
RARβ [29]. We previously found that the depletion of
vitamin A is associated with precancerous lesions in
cigarette smoke-exposed trachea [3]. It has long been
known that retinoic acid has a cancer-preventative effect
because vitamin A-deficient rodents develop squamous
metaplasia, a precancerous lesion [30]. More recently, it
has been discovered that lung RARβ levels return to
normal if rats that were previously fed a vitamin A-
deficient diet were supplemented with retinoic acid [11].
As previously mentioned, we have found that dietary ret-
inoic acid can reverse some of the increased lung
cancer-related gene expression in response to cigarette
smoke in rats [19]. The role of vitamin A in protection
against cigarette smoke-induced cancer is an important
area for further research.
Because RARβ acts as a tumor suppressor gene, its
reduced expression could lead to enhanced cell prolifer-
ation and potentially to tumor formation. It has previ-
ously been shown that an antagonist to RARβ can
abolish the retinoic acid inhibition of mitogenic path-
ways, extracellular signal regulated kinase (ERK 1/2),
and cJun N-terminal kinase (JNK) in human scleral
fibroblasts [31]. In the present study, a dose dependent
increase in the level of a marker of cell proliferation,
proliferating cell nuclear antigen (PCNA), in cigarette
smoke-exposed groups was observed. Expression of one
of the AP-1 proteins, cJun, also was increased and
strongly correlated with the expression of PCNA. Over-
expression of AP-1 is found to be associated with
squamous metaplasia and with increased expression of
PCNA in the lung [8]. Mechanistically, the RARβ DNA
binding domain was important for inhibition of AP-1
activity [32]. In addition, it is found that RARβ has
unique anti-AP-1 activity in that it exhibits strong inhib-
ition of AP-1 activity via protein-protein interaction in
the absence of the ligand retinoic acid [33, 34]. It is in-
teresting to note that in the present study the increased
RARα response closely resembles the increased cJun
response to the smoke exposure, whereas there did not
appear to be a significant inverse relationship betweenRARβ and cJun suggesting independent responses for
RARα and RARβ to the cigarette smoke.
Role of RARα in Lung Cancer
Decreases in retinoic acid increase AP-1 transcriptional
activity [34] and thereby increases the expression of cJun
genes. Retinoic acid is also found to down-regulate the
transcriptional activity by cJun in bacteria [35]. Findings
of the present study suggest that an increase cJun-
mediated AP-1 transcriptional activity observed in retin-
oic acid-deficient, cigarette smoke-exposed rat lungs can
be more attributed to an agonistic mechanism via RARα
over-expression than reduction in RARβ-mediated an-
tagonistic response. cJun levels measured in rat lungs
closely replicated the threshold-response demonstrated
by RARα expression in response to the cigarette smoke
exposure. No significant increases were observed until
the dose of cigarette smoke exposure reached 3 packs/d.
This apparent parallel response suggests a cooperative
interaction of RARα and AP-1 as reported previously
using T47D breast cancer cells [36].
Role of cell cyclin irregularity in lung cancer
Next, we investigated cyclins involved in promoting G1
phase to S phase transition to observe changes in factors
related to cell cycle regulation. In the majority of cells/
tissues that have been examined, cell cycle regulation oc-
curs in the G1 phase. Moreover, the connection between
cyclins and cancer has been substantiated with G1-type
cyclins since G1 phase to S phase progression is a key
factor in carcinogenesis [12].
Cyclin E
Cylin E regulates late G1 and early S phases [37]. Cyclin
E, forming complexes with cyclin-dependent kinase 2, is
essential for G1/S transition and has a profound role in
oncogenesis. Both cyclin E and D1 were overexpressed
in the lung exposed to heavy cigarette smoke in the
present experiment. The overexpression of cyclin E and
D1 in the lungs of rats exposed to cigarette smoke sug-
gests a promotion of S phase entry for cell proliferation.
In this study, only the decrease of RARβ and increase
of cyclin E and PCNA were dose-dependent with regard
to cigarette smoke exposure, suggesting a potential rela-
tionship. These results indicate that cigarette smoke ex-
posure plays a significant role in these alterations. Cyclin
E levels determine the time point when cells enter S
phase [37, 38]. In addition, of the two cyclins measured
in this study, only cyclin E was strongly associated with
the concentration of retinoic acid and level of RARβ.
Together, these data suggest that increased cell prolifera-
tion in response to increased expression of cyclin E is
associated with the decrease of RARβ in lungs exposed
to cigarette smoke.
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Unlike cyclin E, cyclin D-type cyclins are synthesized in
early G1 phase. Previous studies have reported an in-
crease in cyclin D1 expression in non-small-cell lung
cancer (NSCLC) cases [39]. cJun is reported to promote
G1 phase progression through direct transcriptional con-
trol of cyclin D1 [40].
Our study suggested that, similar to RARα, cyclin D1
expression increased in a dose-dependent manner
according to increasing cigarette smoke exposure; no
significant increases were demonstrated in cyclin D1
levels until cigarette smoke exposure reached 3 packs/
d. Cyclin D1 levels measured across the treatment
groups were inversely related to lung retinoic acid
levels (P < 0.05). Cyclin D1 levels were also very
strongly associated with cJun levels measured by West-
ern Blot (r = 0.98, P < 0.001). Together, these findings
suggest that RARα, cJun, and cyclin D1 act in concert
to promote cigarette smoke induced cell proliferation
independently of RARβ.Role of RARγ in lung cancer
RARγ levels in the lung were shown to decrease in a
dose-dependent fashion with increasing cigarette expos-
ure (Fig. 2). RARγ has been associated with elastin pro-
duction [41], and its reduced expression appears to be
associated with the development of emphysema [42].
Decreased RARγ has also been found to be depleted in
41 % of non-small-cell lung cancer [43]. The precise role
for RARγ in cigarette smoke-induced lung cancer needs
further investigation.Conclusion
Cigarette smoke-induced retinoic acid deficiency was
found to be highly associated with multiple molecular
biomarkers of increased lung cancer risk in this study.
Increasing cigarette smoke exposure depleted lung retin-
oic acid and decreased RARβ and RARγ expression in a
dose-dependent fashion. The decreased RARβ expres-
sion was associated with a dose-dependent increase in
cyclin E and PCNA. The smoke exposure increased
RARα in a curvilinear fashion. This curvilinear response
was also observed for cyclin D1 and cJun. Two inde-
pendent signal cascades mediated by decreased RARβ
and increased RARα expression may contribute to the
precancerous lesions observed from our previous study
[3]. Whether the transcription regulation in this model
through epigenetics or transcription factor:DNA interac-
tions as measured by a ChIP assay and whether the
addition of dietary vitamin A in conjunction with
cigarette smoke exposure prevents and/or decreases lung
cancer risk are worth future exploration.Abbreviations
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